FDA
approval
· 2018-12-20
FDA Approved: LITHIUM CARBONATE ER — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA approved a supplemental application for Lithium carbonate ER submitted by Glenmark Pharmaceuticals Inc., USA, representing an approved change to an existing…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LITHIUM CARBONATE ER (LITHIUM CARBONATE)